NCT06564012Not yet recruiting
Wearable Cardiac Monitor to Enhance Detection of Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 25 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The WEAR-AF study is a prospective, multicenter clinical trial designed to evaluate the efficacy of wearable technology in the detection, monitoring, and management of atrial fibrillation (AF). This study aims to assess how wearable devices, such as smartwatches equipped with electrocardiogram (ECG) capabilities, can be used to identify AF episodes, guide treatment decisions, and ultimately improve patient outcomes. Participants will be individuals diagnosed with or at high risk for atrial fibrillation. The study will track the accuracy of AF detection, patient adherence to monitoring, and the impact on clinical outcomes, including stroke prevention, symptom management, and quality of life. The findings from WEAR-AF are expected to contribute to the growing body of evidence supporting the integration of wearable technology into routine clinical practice for AF management, offering insights into its potential to enhance patient care and reduce healthcare costs.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 19 Aug 2024
- Start date
- 1 Jul 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Sunnybrook Health Sciences Centre
- Diseases
- Stroke, Atrial fibrillation
- NCT number
- NCT06564012
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Jul 2025 to the primary completion date, 31 Dec 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Adverse reaction to Skiin garments (e.g. skin allergy)
- The relevant Skiin Underwear contraindications acting as exclusion criteria for this study are:
Other
- Pacemaker and/or (ICD) implantable cardioverter defibrillator users.
- Pregnancy
Who the study is looking for
- Adults aged 18 years or older.
- Diagnosed with paroxysmal or persistent atrial fibrillation.
- Scheduled to undergo catheter ablation for atrial fibrillation.
- Able to provide informed consent.
- Willing to wear the Skiin garments (chest band or bralette) for the duration of the study (approximately 1 month pre and 6 months post-ablation).
- Have a smartphone with an Operating System compatible with the Skiin Connected Life App (Android 9+ or iOS 13+)
Age in the registry: 18 years to - · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.